ECP
NUVA

Empyrean Capital Partners’s NuVasive, Inc. NUVA Stock Holding History

Empyrean Capital Partners’s Portfolio NUVA Stock Details NUVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-11,900
Closed -$662K – 88
2020
Q2 		$662K Buy
+11,900
New +$688K 0.04% 63
2016
Q2 		– Sell
-27,000
Closed -$1.31M – 98
2016
Q1 		$1.31M Buy
+27,000
New +$1.23M 0.05% 75

Other funds holding NUVA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ACA
Anchor Capital Advisors Boston, Massachusetts $3.51B AUM 16.99% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

Empyrean Capital Partners's NUVA Position: Q3 2020 in Review

Empyrean Capital Partners sold out of NuVasive, Inc. (NUVA) in Q3 2020, closing a stake of 11,900 shares — an estimated $662K sold.

Empyrean Capital Partners first reported a position in NUVA in Q1 2016 and held it in 2 quarters. The position peaked at $1.31M in Q1 2016. 263 funds tracked by Wall St. Rank hold NUVA as of Q3 2020.

  • Empyrean Capital Partners reported no remaining NuVasive, Inc. position as of Q3 2020 after selling out during the quarter.
  • Empyrean Capital Partners sold 11,900 NuVasive, Inc. shares in Q3 2020, an estimated $662K.
  • Empyrean Capital Partners first reported a position in NuVasive, Inc. in Q1 2016 and held it in 2 quarters.
  • Empyrean Capital Partners's NuVasive, Inc. position peaked at $1.31M in Q1 2016.
  • 263 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q3 2020.

Based on Empyrean Capital Partners's 13F filing for Q3 2020, filed 16 Nov 2020.